Skip to main content
Log in

Valaciclovir suppressive vs episodic therapy for QOL in herpes genitalis

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valaciclovir suppressive vs episodic therapy for QOL in herpes genitalis. Pharmacoecon. Outcomes News 408, 10 (2003). https://doi.org/10.1007/BF03276133

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03276133

Keywords

Navigation